April 10, 2026
SOHO Insider Hem/Onc Library Multiple Myeloma

Multiple Myeloma News

Microscope in AI virtual pattern
SOHO 2025 Ambassador Program Lymphoma Aggressive B-Cell Lymphomas Multiple Myeloma News

Dr. Raheel Iftikhar weighs in on AI in blood cancers

poster_walks_960x520
SOHO 2026 Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Don’t miss SOHO 2026 poster walks

Japanese flag
Cellular Therapy Multiple Myeloma News

Japan’s PMDA clears phase 3 trial of eque-cel in relapsed or refractory MM

SOHO 2026 Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms Society Updates

Registration now open for SOHO 2026, receive early bird rates until June 10

Jeffrey Matous
Community Oncology News Trending now Community Oncology Cellular Therapy Multiple Myeloma Video Interviews

Dr. Jeffrey Matous on managing access to novel agents in the community setting

blood smear
Trending now Leukemia Chronic Lymphocytic Leukemia Multiple Myeloma

Researchers find concomitant MM and CLL are clonally unrelated

New community oncology sessions
Community Oncology News Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News

Drs. Krish Patel and Gwen Nichols join SOHO Insider community oncology series

SOHO UK Leukemia Acute Lymphoblastic Leukemia Multiple Myeloma Myelodysplastic Syndromes News Video Interviews

Dr. Jessica Manson discusses multidisciplinary HLH management at SOHO UK

SOHO Insider podcast
Cellular Therapy Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Multiple Myeloma Myelodysplastic Syndromes News

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

FDA stamp on white paper
Cellular Therapy Multiple Myeloma News

FDA accepts NDA for iberdomide in relapsed/refractory myeloma